Advanced search
Publication Cover
Current Medical Research and Opinion Volume 16, 2000 - Issue 1
Submit an article Journal homepage
115
Views
26
CrossRef citations to date
0
Altmetric
Research-article

Effect of Rifaximin on Intestinal Bacterial Overgrowth in Crohn's Disease as Assessed by the H2-Glucose Breath Test

L. Biancone Istituto di Clinica Medica 2, Università ‘La Sapienza’, Rome, Italy
,
P. Vernia Istituto di Clinica Medica 2, Università ‘La Sapienza’, Rome, Italy
,
D. Agostini Istituto di Clinica Medica 2, Università ‘La Sapienza’, Rome, Italy
,
A. Ferrieri Direzione Medica Alfa Wassermann S.p.A., Bologna, Italy
&
F. Pallone Dipartimento di Medicina Interna, Università di Roma ‘Tor Vergata’, Rome, Italy
Pages 14-20 | Published online: 06 Aug 2008

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jinsheng Wang, Lei Zhang & Xiaohua Hou. (2021) Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis. Expert Review of Gastroenterology & Hepatology 15:12, pages 1385-1399.
Read now
Loris R. Lopetuso, Marco Napoli, Gianenrico Rizzatti & Antonio Gasbarrini. (2018) The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease. Expert Opinion on Investigational Drugs 27:6, pages 543-551.
Read now
Francesca Romana Ponziani, Viviana Gerardi & Antonio Gasbarrini. (2016) Diagnosis and treatment of small intestinal bacterial overgrowth. Expert Review of Gastroenterology & Hepatology 10:2, pages 215-227.
Read now
E.A. Debbia, E. Maioli, S. Roveta & A. Marchese. (2008) Effects of Rifaximin on Bacterial Virulence Mechanisms at Supra- and Sub-Inhibitory Concentrations. Journal of Chemotherapy 20:2, pages 186-194.
Read now

Articles from other publishers (22)

Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov & Vladimir Ivashkin. (2023) Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 29:27, pages 4236-4251.
Crossref
Georgia Brown, Emily C. Hoedt, Simon Keely, Ayesha Shah, Marjorie M. Walker, Gerald Holtmann & Nicholas J. Talley. (2022) Role of the duodenal microbiota in functional dyspepsia. Neurogastroenterology & Motility 34:11.
Crossref
Kyeong Ok Kim. (2022) Functional Gastrointestinal Disorders in Patients with Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 79:1, pages 4-11.
Crossref
Cristina Tocia, Irina Magdalena Dumitru, Luana Alexandrescu, Lucian Cristian Petcu & Eugen Dumitru. (2021) Does rifaximin offer any promise in Crohn's disease in remission and concurrent irritable bowel syndrome-like symptoms?. Medicine 100:1, pages e24059.
Crossref
Phillip Gu, Devin Patel, Krutika Lakhoo, Jeffrey Ko, Xiaochen Liu, Bianca Chang, Dana Pan, Greg Lentz, Matthew Sonesen, Renier Estiandan, Eugenia Lin, Mark Pimentel & Ali Rezaie. (2019) Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. Digestive Diseases and Sciences 65:8, pages 2388-2396.
Crossref
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen & A Barney Hawthorne. (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68:Suppl 3, pages s1-s106.
Crossref
Gaurav Ghosh & Arun B. Jesudian. (2019) Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis. Journal of Clinical and Experimental Hepatology 9:2, pages 257-267.
Crossref
Jean-Frederic Colombel, Andrea Shin & Peter R. Gibson. (2019) AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review. Clinical Gastroenterology and Hepatology 17:3, pages 380-390.e1.
Crossref
L. Gatta & C. Scarpignato. (2017) Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Alimentary Pharmacology & Therapeutics 45:5, pages 604-616.
Crossref
LIHUA DENG, YANG LIU, DONGSHENG ZHANG, YUAN LI & LIN XU. (2016) Prevalence and treatment of small intestinal bacterial overgrowth in postoperative patients with colorectal cancer. Molecular and Clinical Oncology 4:5, pages 883-887.
Crossref
Orna Nitzan. (2016) Role of antibiotics for treatment of inflammatory bowel disease. World Journal of Gastroenterology 22:3, pages 1078.
Crossref
R. B. Sartor. (2016) Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics 43, pages 27-36.
Crossref
Leonard B. Weinstock & Arthur S. Walters. 2015. Modulation of Sleep by Obesity, Diabetes, Age, and Diet. Modulation of Sleep by Obesity, Diabetes, Age, and Diet 235 242 .
Doron Boltin, Tsachi Tsadok Perets, Einav Shporn, Shoshana Aizic, Sigal Levy, Yaron Niv & Ram Dickman. (2014) Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome. Annals of Clinical Microbiology and Antimicrobials 13:1.
Crossref
Arvind Srinath, Erin Young & Eva Szigethy. (2014) Pain Management in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:12, pages 2433-2449.
Crossref
C. Scarpignato & L. Gatta. (2013) Commentary: towards an effective and safe treatment of small intestine bacterial overgrowth. Alimentary Pharmacology & Therapeutics 38:11-12, pages 1409-1410.
Crossref
S. C. Shah, L. W. Day, M. Somsouk & J. L. Sewell. (2013) Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Alimentary Pharmacology & Therapeutics 38:8, pages 925-934.
Crossref
Heimo H. Wenzl. (2012) Diarrhea in Chronic Inflammatory Bowel Diseases. Gastroenterology Clinics of North America 41:3, pages 651-675.
Crossref
Leonard B WEINSTOCK & Suzie ZEISS. (2012) Rifaximin antibiotic treatment for restless legs syndrome: a double-blind, placebo-controlled study. Sleep and Biological Rhythms 10:2, pages 145-153.
Crossref
Leonard B. Weinstock, Brian P. Bosworth, Ellen J. Scherl, Ellen Li, Ugonna Iroku, Melissa A. Munsell, Gerald E. Mullen & Arthur S. Walters. (2010) Crohnʼs disease is associated with restless legs syndrome. Inflammatory Bowel Diseases 16:2, pages 275-279.
Crossref
Thomas R. Ziegler & Conrad R. Cole. (2007) Small bowel bacterial overgrowth in adults: A potential contributor to intestinal failure. Current Gastroenterology Reports 9:6, pages 463-467.
Crossref
Marek Majewski, Savio C. Reddymasu, Sandra Sostarich, Pernilla Foran & Richard W. McCallum. (2007) Efficacy of Rifaximin, a Nonabsorbed Oral Antibiotic, in the Treatment of Small Intestinal Bacterial Overgrowth. The American Journal of the Medical Sciences 333:5, pages 266-270.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.